About the Authors
- Jae-Won Hyun
-
Affiliations Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea, Ewha Womans University, Graduate School of Medicine, Seoul, Korea
- Su-Hyun Kim
-
Affiliation Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea
- In Hye Jeong
-
Affiliation Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea
- Suk-Won Ahn
-
Affiliation Chung-Ang University, College of Medicine, Seoul, Korea
- So-Young Huh
-
Affiliation Kosin University, College of Medicine, Busan, Korea
- Min Su Park
-
Affiliation Yeungnam University, College of Medicine, Daegu, Korea
- Young In Eom
-
Affiliation Ajou University, School of Medicine, Suwon, Korea
- In Soo Joo
-
Affiliation Ajou University, School of Medicine, Suwon, Korea
- Joong-Yang Cho
-
Affiliation Ilsan Paik Hospital, Inje University, College of Medicine, Goyang, Korea
- Eun Bin Cho
-
Affiliations Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea, Neuroscience Center, Samsung Medical Center, Seoul, Korea
- Ju-Hong Min
-
Affiliations Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea, Neuroscience Center, Samsung Medical Center, Seoul, Korea
- Byoung Joon Kim
-
Affiliations Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea, Neuroscience Center, Samsung Medical Center, Seoul, Korea
- Nam-Hee Kim
-
Affiliation Dongguk University Ilsan Hospital, Goyang, Korea
- Jeeyoung Oh
-
Affiliation Konkuk University, School of Medicine, Seoul, Korea
- Kee Duk Park
-
Affiliation Ewha Womans University, Graduate School of Medicine, Seoul, Korea
- Ho Jin Kim
-
* E-mail: hojinkim@ncc.re.kr
Affiliation Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea
Competing Interests
Dr. HJ Kim has received honoraria for speaking or consulting from Bayer Schering Pharma, Biogen Idec, Genzyme, Merck Serono, Novartis, MedImmune, and Teva-Handok and has received research grants from Genzyme, Merck Serono, and Kael-GemVax. He serves on a steering committee for MedImmune and serves as an editorial board member of Multiple Sclerosis Journal—Experimental, Translational and Clinical. Dr. NH Kim has received honoraria for speaking or consulting from Bayer Schering Pharma, UCB, Merck Serono, and Novartis. Dr. J Oh has received honoraria for speaking or consulting from Genzyme. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: JWH HJK SHK. Performed the experiments: JWH HJK SHK IHJ SWA SYH MSP YIE ISJ JYC EBC JHM BJK NHK JO KDP. Analyzed the data: JWH HJK SHK IHJ SWA SYH MSP YIE ISJ JYC EBC JHM BJK NHK JO KDP. Contributed reagents/materials/analysis tools: JWH HJK SHK. Wrote the paper: JWH HJK SHK IHJ SWA SYH MSP YIE ISJ JYC EBC JHM BJK NHK JO KDP.